🔎 Trials Near Me

Home › Heart Failure › NCT06812533

Alleviant ALLAY-HFrEF Study

Recruiting

Safety and Efficacy of the Alleviant No-Implant Interatrial Shunt in Patients With Heart Failure and Reduced Ejection Fraction

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* LVEF ≤ 40%
* NYHA class II, III or ambulatory IV HF
* Receiving optimal, maximally tolerated, stable GDMT

Exclusion Criteria:

* Advanced heart failure
* Life-expectancy \< 12 months
* Evidence of right heart dysfunction

About the study

Prospective, multicenter, randomized, sham-controlled, double blind (patient and observer), study designed to evaluate the safety and efficacy of a percutaneously created interatrial shunt using the Alleviant ALV1 System in patients with HFrEF.

What is being tested

Sponsor: Alleviant Medical, Inc. · Participants: 350 · Started: Mar 10, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT06812533

Locations in the U.S.

CaliforniaKeck Medical Center of USC, Los Angeles
University California Los Angeles Medical Center, Los Angeles
UC Davis Medical Center, Sacramento
Scripps Clinical Research Services, San Diego
University of California San Francisco, San Francisco
FloridaDelray Medical Center, Delray Beach
Ascension Sacred Heart, Pensacola
Tampa General Hospital, Tampa
GeorgiaAtlanta VA Health Care System, Decatur
IllinoisMidwest Cardiovascular Institute, Naperville
LouisianaCardiovascular Institute of the South, Houma
University Medical Center New Orleans, New Orleans
MassachusettsBoston Medical Center, Boston
Brigham and Women's Hospital, Boston
Tufts Medical Center, Boston
MinnesotaMinneapolis Heart Institute Foundation, Minneapolis
MissouriWashington University - St Louis, St Louis
NevadaUMC of Southern Nevada, Las Vegas
New JerseyDeborah Heart & Lung Center, Browns Mills
Englewood Medical Center, Englewood
New YorkStony Brook Medicine, New York
Rochester General Hospital, Rochester
University of Rochester Medical Center, Rochester (Not yet recruiting)
North CarolinaMission Hospital, Asheville
Duke University Hospital, Durham
NC Heart and Vascular Research, Raleigh
OhioCleveland Clinic, Cleveland
ProMedica Toledo Hospital, Toledo
PennsylvaniaPinnacle Health Cardiovascular Institute, Harrisburg
South CarolinaMedical University of South Carolina, Charleston
Roper St. Francis Healthcare, Charleston
South DakotaMonument Health, Rapid City
TennesseeTennova Healthcare - Turkey Creek Medical Center, Knoxville
TexasHendrick Health, Abilene
Austin Heart, Austin
Baylor Scott & White Research Institute, Plano
Baylor Scott & White - Temple, Temple
Waco Cardiology, Waco
VirginiaCarilion Clinic, Roanoke

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.